Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1971 1
1972 2
1973 3
1974 2
1975 4
1976 3
1977 3
1978 5
1979 2
1980 5
1981 2
1982 3
1983 5
1984 6
1986 4
1987 5
1988 4
1989 2
1990 3
1991 6
1992 6
1993 5
1994 10
1995 12
1996 12
1997 9
1998 7
1999 10
2000 16
2001 12
2002 7
2003 14
2004 12
2005 19
2006 20
2007 18
2008 22
2009 19
2010 25
2011 20
2012 27
2013 28
2014 29
2015 49
2016 60
2017 60
2018 52
2019 27
2020 59
2021 58
2022 64
2023 75
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

862 results

Results by year

Filters applied: . Clear all
Page 1
Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.
D'Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R, Agarwal JP, Pantvaidya G, Chaukar D, Deshmukh A, Kane S, Arya S, Ghosh-Laskar S, Chaturvedi P, Pai P, Nair S, Nair D, Badwe R; Head and Neck Disease Management Group. D'Cruz AK, et al. N Engl J Med. 2015 Aug 6;373(6):521-9. doi: 10.1056/NEJMoa1506007. Epub 2015 May 31. N Engl J Med. 2015. PMID: 26027881 Free article. Clinical Trial.
Comparison of the Barrett Universal II, Kane and VRF-G formulas with existing intraocular lens calculation formulas in eyes with short axial lengths.
Voytsekhivskyy OV, Tutchenko L, Hipólito-Fernandes D. Voytsekhivskyy OV, et al. Eye (Lond). 2023 Jan;37(1):120-126. doi: 10.1038/s41433-021-01890-7. Epub 2022 Jan 15. Eye (Lond). 2023. PMID: 35031707 Free PMC article.
BACKGROUND: To compare the accuracy of recently developed modern intraocular lens (IOL) power formulas (Barrett Universal II, Kane and VRF-G) with existing IOL power formulas in eyes with an axial length (AL) 22 mm. ...Statistically significant differences were foun …
BACKGROUND: To compare the accuracy of recently developed modern intraocular lens (IOL) power formulas (Barrett Universal II, Kane an …
Splenic Sequestration Crisis.
Kane I, Kumar A, Atalla E, Nagalli S. Kane I, et al. 2023 Jun 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jun 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 31985957 Free Books & Documents.
Splenic sequestration is a feared complication of sickle cell anemia that primarily affects young children. It is an acute drop in hemoglobin of 2 g/dL accompanied by splenomegaly. The spleen is at particular risk for complications from sickle cell anemia due to its role a …
Splenic sequestration is a feared complication of sickle cell anemia that primarily affects young children. It is an acute drop in hemoglobi …
VRF-G, a New Intraocular Lens Power Calculation Formula: A 13-Formulas Comparison Study.
Hipólito-Fernandes D, Elisa Luís M, Gil P, Maduro V, Feijão J, Yeo TK, Voytsekhivskyy O, Alves N. Hipólito-Fernandes D, et al. Clin Ophthalmol. 2020 Dec 16;14:4395-4402. doi: 10.2147/OPTH.S290125. eCollection 2020. Clin Ophthalmol. 2020. PMID: 33364744 Free PMC article.
The Kane formula had the highest percentage of eyes within 0.25D (47.0%) and 1.00D (97.7%) and the VRF-G formula had the highest percentage of eyes within 0.50D (79.5%). For all AL subgroups, Kane, EVO 2.0 and VRF-G formulas had the most accurate perfo …
The Kane formula had the highest percentage of eyes within 0.25D (47.0%) and 1.00D (97.7%) and the VRF-G formula had the highe …
Clopidogrel Therapy and CYP2C19 Genotype.
Dean L, Kane M. Dean L, et al. 2012 Mar 8 [updated 2022 Dec 1]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–. 2012 Mar 8 [updated 2022 Dec 1]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–. PMID: 28520346 Free Books & Documents. Review.
The warning states that tests are available to identify individuals who are CYP2C19 PMs, and to consider the use of another platelet P2Y(12) (purinergic receptor P2Y, G-protein coupled 12) inhibitor in individuals identified as CYP2C19 PMs. ...
The warning states that tests are available to identify individuals who are CYP2C19 PMs, and to consider the use of another platelet P2Y(12) …
Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial.
Wang D, Zhang Q, Eisenberg BL, Kane JM, Li XA, Lucas D, Petersen IA, DeLaney TF, Freeman CR, Finkelstein SE, Hitchcock YJ, Bedi M, Singh AK, Dundas G, Kirsch DG. Wang D, et al. J Clin Oncol. 2015 Jul 10;33(20):2231-8. doi: 10.1200/JCO.2014.58.5828. Epub 2015 Feb 9. J Clin Oncol. 2015. PMID: 25667281 Free PMC article. Clinical Trial.
Treatment-resistant schizophrenic patients.
Kane JM. Kane JM. J Clin Psychiatry. 1996;57 Suppl 9:35-40. J Clin Psychiatry. 1996. PMID: 8823348 Review.
Despite the proven efficacy of antipsychotic medication in the treatment of schizophrenia, a substantial proportion of patients derive little if any benefit from traditional medications. Though alternative strategies (e.g., increasing dosage, switching antipsychotic, or ad …
Despite the proven efficacy of antipsychotic medication in the treatment of schizophrenia, a substantial proportion of patients derive littl …
Gentamicin Therapy and MT-RNR1 Genotype.
Dean L, Kane M. Dean L, et al. 2015 Apr 29 [updated 2022 Sep 22]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–. 2015 Apr 29 [updated 2022 Sep 22]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–. PMID: 28520359 Free Books & Documents. Review.
Substantial literature has reported that a high proportion of individuals with the MT-RNR1 m.1555A>G variant (NC_012920.1:m.1555A>G) develop hearing loss after receiving aminoglycoside therapy. ...
Substantial literature has reported that a high proportion of individuals with the MT-RNR1 m.1555A>G variant (NC_012920.1:m.1555A& …
Accuracy of 24 IOL Power Calculation Methods.
Voytsekhivskyy OV, Hoffer KJ, Tutchenko L, Cooke DL, Savini G. Voytsekhivskyy OV, et al. J Refract Surg. 2023 Apr;39(4):249-256. doi: 10.3928/1081597X-20230131-01. Epub 2023 Apr 1. J Refract Surg. 2023. PMID: 37040214

The heteroscedastic method revealed statistically significant differences (P < .05) among formulas. Newly developed methods such as the VRF-G (standard deviation [SD] 0.387 D), Kane (SD 0.395 D), Hoffer QST (SD 0.404 D), and Barrett Universal II (SD 0.405) were m

…

The heteroscedastic method revealed statistically significant differences (P < .05) among formulas. Newly developed methods such as the V

…
Capecitabine Therapy and DPYD Genotype.
Dean L, Kane M. Dean L, et al. 2016 Sep 15 [updated 2020 Nov 2]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–. 2016 Sep 15 [updated 2020 Nov 2]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–. PMID: 28520372 Free Books & Documents. Review.
Individuals who have at least one copy of a nonfunctional DPYD variant (for example, c.1905+1G>A (formerly *2A; rs3918290) or c.1679T>G (p.I560S; formerly *13; rs55886062)) will not be able to metabolize fluorouracil at normal rates. ...
Individuals who have at least one copy of a nonfunctional DPYD variant (for example, c.1905+1G>A (formerly *2A; rs3918290) or c.1679T> …
862 results